Marc Beer, through Renovia Inc., a startup he co-founded, has just made a significant contribution to the improvement of the health of women in Boston. Beer, who also founded the ViaCell, Inc. and served as its chief for seven years, has through this step demonstrated leadership. This act shows that he has not been consumed into the deep chambers of his career; the profits and loses; that he cares for the wellbeing of other people. This is not a common feat with many people who have held senior managerial positions in numerous companies. In a statement expressing his delight at being joined by the Longwood Fund for this work, Beer indeed acknowledged that he has a vision ‘to better diagnose, treat and improve the lives of millions of women affected by pelvic floor disorders’ around the world.
This donation will come in two packages; $32m for new equipment and the rest ($10m) in venture debt. Marc Beer’s contribution is set to be used for the development of material used for diagnosis and therapy to fight pelvic floor disorders which are estimated by medical researchers to affect about 250 million women in the world.
Beer, who has a lot of experience at sales and marketing management, has also excelled in research and development program management in therapeutic, surgical and in vitro diagnostic systems businesses. He has also served as a private consultant in the field of medical industry. After graduating with a Bachelors of Science in Business Administration from Miami University in Ohio, Beer grew career-wise to hold many top positions in companies doing business in the medical field. He has been a director at CytoPherx, Seaside Therapeutics LLC, Erytech Pharma Société Anonyme and Viacell companies the latest at which he also held the position of chairman. He has also served in the managerial boards, notably the Scientific and Medical Advisory Board at TxCell Promises, the Mass Life Science Board of the Commonwealth of Massachusetts as well as the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Body.
In taking this bold step, Beer has demonstrated that successful individuals need to use their expertise in not only building their companies and countries but also in giving back to society. Learn more: https://www.slideshare.net/MarcBeer
Marc Beer and his new startup company called Renovia, announced that after recently doing a $32 million Series B round, they will continue several new products that have to do with pelvic floor disorders.
The medical technology company, based in Boston, has created many different kinds of products to help people with such symptoms of pelvic disorders as urinary incontinence. 250 million women around the world have to deal with urinary incontinence. Renovia did recently get FDA approval of their first product called Leva.
What helped Renovia get through the Series B round is Longwood Fun, a medical care- investing firm. A Ascension Ventures company from Missouri and Perceptive Advisors from New York also helped Renovia get through this round. Funding the creation and testing of more diagnostic and therapeutic products including a new version of Leva came from the above companies.
Marc Beer, the CEO of Renovia, is excited by the support that he gets from medical care investors who have the same vision that he and his company of. They all want to improve the lives of millions of women that have to deal with pelvic disorders. His combines proprietary and innovative sensor technologies and form factors with a virtual health platform that inform their customers about treatment options. This should hopefully lead to more knowledge and understanding about pelvic disorders and should lead to cheaper long-term healthcare costs.
Marc Beer is 52 years old and Renovia is not the only company that he founded. He also founded Good Start Genetics.
He does have some spare time to be a member of other organizations that have nothing to do with his day job. He has been a part of Notre Dame Research Advisory and Notre Dame Research and Communications Advisory Committee.
Marc Beer attended Miami University (Ohio) and got a Bachelor of Science degree. It is not known for some reason what his major was at this university.
The first company that he was known to have founded was ViaCell. He founded it in April of 2000. This biotech firm focused on collecting, preserving and developing umbilical cord blood. When he left this organization, it had become a robust organization that would continue to thrive and grow into the future. By the time it was bought in 2007 by Perkin Elmer, it had 300 employees. It is hoped that he has the same success with his current company. Learn more: https://www.linkedin.com/in/marcbeer
Mark Beer studied at the Miami University located in Ohio graduating with a Bachelor of Science. Today, the individual is a renowned entrepreneur and philanthropist. After completing school, Beer specialized working in diagnostic, pharmaceutical, device, and biotechnology where he worked for over 25 years. During the 25 years, the individual garnered much experience in operation to thorough his career. In 2016, Beer established Renovia Inc. Shortly after starting up the business, the group underwent through the series A funding project. Among many other convergences of technology and medicine, Renovia is the most favorable and recent achievement of Mark Beer. These numerous achievements and the positions Beer held made him suitable to stand as the leader of Renovia.
The $42-million series B funding completed showed great development not just for Renovia but for Mark Beer and the entire Ohio community. Beer showed his leadership skills when he became the chief executive officer of ViaCell. The institution dealt with the development and preservation of the umbilical-cord stem cells. ViaCell later got acquired by the Perkin Elmer who had much experience in the industry. ViaCell opened doors to the public in 2005. Before getting its new possession, the organization had more than 300 employees. Mark Beer worked himself up through various leadership positions. Other posts Beer occupied include the executive vice president of global marketing. All these posts help Beer to develop much experience in diagnostic and pharmaceutical sections. The positions Beer held did not just develop his career in medicine but also gave him a chance to learn what the clients need. Therefore, the patients at Renovia have the right team of leadership in position.
Through the leadership of Mark Beer, Renovia established a product known as Leva. The commodity has a design to help women regain the health of the pelvic floor. The problem of the pelvic floor is spreading at a higher rate in the entire world. Other than Leva, the Renovia and Mark Beer are working tirelessly to invent new products to the market to fight the disease. The institution uses the Leva pelvic digital health system for women to have a quick recovery through exercise. The group uses this training product for the women to ensure that they benefit from the activities by doing them in the right manner. Other body issues appear as a result of the poor pelvic floor health and straightening. When the pelvic floor muscles are weak, you get pelvic floor disorder.
Renovia used some of its resources and funds to open up new clinical trials that began this year. The clinics will determine the effect of Leva on women who use the product when exercising as compared to those who do not use. The institution expected a turnout of over 225 women. Learn more: https://ideamensch.com/marc-beer/
Renovia’s CEO Marc Beer Raises Over $40 Million in Funding and Debt Venture
Marc Beer, the CEO of Renovia has 25 plus years of expertise in the biotechnology, diagnostics, and pharmaceutical industries. Gazette reported the beginning of October 2018 that he raised $32 million in funds and $10 million in venture debt for his new start-up company. He started the company with Ramon Iglesias and Yolanda Lorie as a medical technology entity, in 2016. Their mission is to develop diagnostic and treatment products for women diagnosed with pelvic disorders. Throughout his career, he’s started successful businesses and serves on the board of directors for companies and educational institutions.
When Beer started Renovia, he received his first round of funding from healthcare investment group, Longwood Fund. With the help of Perceptive Advisers and Ascension Ventures, he raised the second round of funding to support four of their products. In April of this year, the FDA approved a new product, Leva produced by the company. Marc told Gazette he now can improve the diagnosis and treatment for women diagnosed with the pelvic disorder. He plans to lead the development with the combination of proprietary technologies and a digital health forum.
The technologies and forum will provide educational and informative information that produces treatment options to customers. The goal is to increase understanding of the disorder that will eventually lead to reducing health care costs long term. Marc Beer explains that they designed treatments to restore pelvic health using various solutions to strengthen the muscles. He says Renovia plans to create a new generation of Leva for patients suffering from urinary contingency disorders. Pelvic floor disorder effects 250 million women and is treatable with the proper products.
Before co-finding Renovia, Marc Beer found ViaCell, a biotechnology company specializing in the development, preservation, and collection of blood stem cells. He started the business in 2000 and experienced rapid growth within seven years. By 2005, ViaCell became a public traded enterprise with 300 workers. Beer held positions with Global Marketing, Genzyme, Abbott Laboratories, Erytech Pharma, Good Start Genetics, Minerva Neurosciences, and Commonwealth of Massachusetts. His executive titles include vice president, board member director, chief executive officer, and chairman.
Marc is a Miami University graduate earning a BA in Business Science, in 1987. He has over 25 years of experience in development and commercialization in the devices, diagnostics, pharmaceutical, and biotechnology fields. While serving on the board of directors for a cancer foundation, he helped many cancer patients and their families during difficult times. Beer serves as a member of the Miami University Business Advisory Council. He served on the Graduate Studies Research and Advisory Council and the Research and Commercialization Advisory Committee at Notre Dame. Learn more: https://www1.salary.com/Marc-Beer-Salary-Bonus-Stock-Options-for-AEGERION-PHARMACEUTICALS-INC.html
Renovia Inc. has recently closed on $32 million of Series B funding to go ahead with new products treat pelvic floor disorders. The company, which was co-founded by Marc Beer in 2016, also received $10 million in venture capital as well.
The funds will be used to develop four new products addressing pelvic floor ailments, though details were not released by the company. Bizjournals.com said they will address diagnostic and therapeutic improvements that address ailments that may include urinary incontinence. Marc Beer said in a statement the company aims to improve its sensor technology to give healthcare providers the tools to incorporate better data in their treatment strategies. Beer went on to say that these improvements will “eventually” bring down healthcare costs.
The Series B included money from the Longwood Fund, which was an early investor in the Beer’s co-founded company. The Series B process was led by Perspective Advisors, based out of New York, and Missouri-based Ascension Ventures. Renovia Inc. developed the drug Leva, which was approved by the FDA back in April. The Series B funding will partly be used will be used to create a new generation of Leva, it was said in the bizjournals.com article.
Marc Beers joined two others, Ramon Iglesias and Yolanda Lorie, to create Renovia in August 2016 and was instrumental in securing the Series A funding used to develop Leva. The Longwood fund was one of those initial investors. Marc Beers co-founded Renovia Inc. after a long tenure in the medical field, has commercialized a number of products in the areas of biotechnology, pharmaceuticals, devices and diagnostics.
Among other companies he started was ViaCell, a biotechnology company that focuses on the collection, preservation, and development of umbilical cord stem cells. He led the company from inception to its growth to 300 employees to ts eventual sale to PerkinElmer in 2007. Prior to that, Marc Beers was a member of the board of directors of Erytech Pharma and held positions with Genzyme where he served most recently as the vice president of global marketing where he was instrumental in the launch of drugs addressing rare diseases across the globe. Learn more: https://renoviainc.com/leadership/
Marc Beer has extensive experience and expertise in commercialization and development in pharmaceuticals, diagnostics, devices, and biotechnology. Marc Beer cofounded Revonia alongside Yolanda Lorie, MD, and Ramon Iglesias in August 2016. The company has successfully achieved a Series A Financing with top healthcare business capital funds since its creation in 2016.
Marc Beer was appointed the Founding Chief Executive Officer of ViaCell in April 2010. ViaCell is a biotechnology firm that focuses on the activities that are involved in the collection, preservation, and development of blood stem cells of the human umbilical cord. Marc Beer led the management of ViaCell for over seven years. He helped the company to grow from its inception to become one of the rapidly growing firms with the intense commercialization of its products and services.
Marc Beer’s leadership and management of ViaCell helped it to go public in 2005, developed to offer over 300 job opportunities, and later purchased by PerkinElmer in the year 2007. Marc Beer dedicated his time and skills to ensure that he used his position as the CEO of the ViaCell to propel it from its humble beginning to attaining international standards.
Marc Beer was also a Board member of the Board of Directors of Erytech Pharma. Erytech Pharma is a publicly traded company that provides pharmaceutical products and services. He was key personnel in the board as he represented the firm in a variety of development forums. Marc Beer also held a variety of positions in Genzyme. One of the most recent post that Mr. Marc held within Genzyme was that of the Vice President of Global Marketing. Under this rank, Mr. Marc Beer was tasked with the responsibilities of the commercial launching of various products that addressed several rare diseases that affected populations around the globe.
Before joining Genzyme, Marc spent years serving Abbott Laboratories where he held various roles in sales and marketing in the diagnostic and pharmaceutical divisions. Marc was also in the Mass Life Science Board of the Massachusetts Commonwealth. He worked in the Emerging Companies Section Governing Board of the Biotechnology Industry Organization.
Marc Beer was among the founders and Founding Chairman of the Board of directors of Good Start Genetics, Inc. He was also the Chairman of the compensation committee of the organization. The Good Start Genetics, Inc. was purchased by InVatae Company just recently. Marc Beer also played some vital roles in the foundation of Minerva Neurosciences, Inc. Learn more: https://www.bizjournals.com/boston/potmsearch/detail/submission/6457372/Marc_Beer
Graeme Holm is a financial fitness expert and the founder of Infinity Group Australia. Holm started this group so that he could deal with the financial issues that affect a majority of Australians. He created this company in 2013, and so far he has helped many Australians manage their finances and secure their future. Infinity Group Australia operates by the customer-first approach. Their customer oriented approach has been proved to be working by the clients who have benefited. The organization is mainly offering debt reduction and money management services.
Why should you follow Graeme Holm?
In a world where you can barely believe anyone who comes claiming to offer support on matters of finances, why should one believe that Graeme Holm is the real deal? Holm is a first of all register as an MBA Top 100 Broker. He has also worked in the banking sector for 17 years, meaning that he is familiar with the dynamics of the financial sector.
The main reason he formed Infinity Group Australia was to address the challenge that he saw customers encountering when dealing with the banks. The banks did nothing to guide and support their customers who were in need of financial support. Usually, a bank will hand one a loan but will not do any further follow up until when they start claiming the repayment.
Graeme Holm formed Infinity Group to fill the void left by the banks. Once a customer has received a loan from the bank, Infinity Group will help in managing the loan until it is repaid in full.
Personal banker approach
To make the loan repayment simplified, Graeme Holm came up with the idea of personal bankers. These are financial experts who will monitor the financial status of the company’s clients. A personal banker will create a report of the monthly spending of the client after which they will sit down with the client to see which areas need adjustments.
Graeme Holm has formed an award-winning organization that is changing the lives of many Australians. Their clients are saving four times what they used to save in one year. This is an unprecedented change that has seen the average client of the Infinity Group Australia saving $41,000.
Graeme Holm wants to help the people secure their future early by making sure that loans are repaid in the shortest time possible. He is also helping the people realize some of the things they tend to spend a lot of money on are not necessary.
Infinity Group Australia is the solution that Australians need to secure their future. The company is a testimony of the change that guidance and education on financial management can make. People are now making better financial decisions after learning from this company. Learn more : https://angel.co/graeme-holm
Turning a hobby, something you love doing into a career is one of the most fulfilling moments in a person’s life. Over the years people have learned to turn their passion to a successful career and one such person is Clay Hutson, since his childhood Clay Hutson has always enjoyed music and after many years of trying to make things work, he was finally able to turn this passion into a career.
Currently, Clay owns a business in the entertainment industry, and he is a sound engineer who has worked his way through the ranks to emerge a success in the flooded entertainment industry. His company provides remedies for live entertainers. Before establishing his businesses, Clay worked in several organizations and was in charge of live performances as well as live tours.
After many years in the industry, Clay Hutson lost his job. He was however confident that he could make it on his own as he had perfected and gained skills over the years. Clay was confident that he could traverse any sector in the entertainment industry and this confidence contributed highly to the formation of his company.
On a normal day, Clay engages in management, supervising the stages and ensuring that the required equipment is set and the event transitions smoothly from the beginning to the end. Clay works closely with his crew to ensure that the plans turn out a success. Before he settles on other duties Clay ensures that his workers are aware of their responsibility for the day and this ensures perfection in their production.
As a businessman Clay Hutson believes that one of the attributes that have made him succeed in his work being, attention to detail. Every morning Hutson plans his tasks, and this helps him become more productive as he always prepared even in overwhelming projects.
To upcoming entrepreneurs one thing that Clay highly recommends is self-correction, ensure you check your work over and over again. This ensures that you provide quality products and services and in turn, clients get value for their money. This habit has also been a helpful marketing strategy, and this is because Clay mostly depends on word of mouth for people to know about his work.
His previous clients pass around the word to other prospect clients, and due to the quality of his work, he is able to attract new customers often.
Clay Hutson’s story is a great inspiration for aspiring business people, rising from losing his job to becoming a boss, proves that with passion and determination anything is possible. Learn more: https://www.crunchbase.com/person/clayton-hutson-1a2e
Scott Rocklage is a well respected man in the medical field. His career began when he attended the University of California, Berkeley to obtain his Bachelors in Chemistry. Scott Rocklage later attended MIT, where in 2005 he won a Nobel Peace Prize in Chemistry. He currently has over 30 years of experience in the medical field. The work he’s performed on medications, clinical trials, inventions, and publications has made his presence known all throughout the community.
A recently article on the website Medical Daily Times discusses how Scott Rocklage is paving the way for a cure to DM1. That is a genetic disorder more commonly known as Myotonic dystrophy type I. This conditions comes from RNA cells reaching toxic levels when too much protein is converted from DNA. This results in several important body organs becoming defective. As a genetic disorder, many people can be affected within a family. Having this disease can make for challenging times for a family.
In order to combat this disease, several companies have stepped up and donated a lot of money into research. Scott Rocklage recently released a press release about the lab work Matthew Disney has been performing. He states the research they have been working on for the past 12 years has produced results. Molecule medications is best the method to treat the disease. Everyone at the lab is looking forward to seeing how the tests advance. They wish to be able to fully treat any RNA disease someday.
The medical field is always full new advancements in technology. As we come to understand more, our treatment methods also progress. RNA diseases are a rare, but awful ailment in the body. The research has come a long way and has just recently began producing treatment methods. Scott Rocklage is one of those at the center of this research. His team has helped to fund the project and bought their experience along with it. At some point in the future, perhaps we will be freed of such awful diseases. Learn more: https://ideamensch.com/scott-rocklage/
As one might imagine trying to produce a world tour or even a one-off concert is not an easy feat. When an entertainer and their crew are able to pull off a successful concert or tour the audience often walks away satisfied not knowing that what they just witnessed was likely the work of hundreds of people who play a critical role in ensuring that a concert is executed without any hitches. The dreaded delays that can come during a live performance whether it is a show by a stand up comedian, a performance by a group of ballerinas or a highly anticipated show by an A-list performer due to technical difficulties are a testament to the fact that there is much more that goes into a smooth performance than the skill of the person on whom the literal spotlight is trained.
Performers are very much dependent on the stage crew who are responsible for building the sets that they execute their routines on. These crews are responsible for creating the literal landscape of the performer’s tour. For instance the Glow In The Dark tour by Kanye West saw the rapper standing on a moving platform that was covered in mist while images of outer space where projected on the wall behind him. The tour helped to define the rapper as an innovator in his genre and arguably could not have been pulled off without the assistance of a production management team. Production managers like Clayton Hutson are the hidden forces of nature who make legendary performances by the world’s favorite performers come true.
Clayton Hutson has spent years in the entertainment industry working as a production manager and a monitor engineer for various musicians and tours. Clayton Hutson has worked behind the scenes on tours for acts such as Aaron Lewis of the band Staind and R&B singer Maxwell. During his time working on the tour of Staind’s lead singer Aaron Lewis, Clay Hutson was in a role that saw him having various duties. The roles that he was responsible for executing during Aaron Lewis’ tour involved him serving as the monitor engineer and carrying out the quotidian duties that are required of a production manager and a tour manager. In addition to working behind the scenes for Aaron Lewis and Maxwell, Clay Hutson has also worked behind the scenes for other acts that include Marilyn Manson and the band OneRepublic. Learn more: https://www.linkedin.com/pub/dir/Clay/Hutson